Evidence map›Paper›PMID 32200574›Full record

ArticleJournal of veterinary internal medicine2020

Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC study.

Adrian Boswood, Sonya G Gordon, Jens Häggström, Martin Vanselow, Gerhard Wess, Rebecca L Stepien, Mark A Oyama, Bruce W Keene, John Bonagura, Kristin A MacDonald and 30 more

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial, Veterinary
In one paragraph

Article in Journal of veterinary internal medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

40 authors at 20 institutions in 11 countries.

Adrian BoswoodDepartment of Clinical Science and Services, The Royal Veterinary College, Hatfield, Hertfordshire, UK.ORCID https://orcid.org/0000-0003-1795-4364
Sonya G GordonDepartment of Small Animal Clinical Sciences, Texas A&M University, College Station, Texas.
Jens HäggströmDepartment of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden.ORCID https://orcid.org/0000-0003-3402-023X
Martin VanselowBiometrie and Statistik, Hannover, Germany.
Gerhard WessClinic of Small Animal Medicine, University of Munich, Munich, Germany.ORCID https://orcid.org/0000-0002-6634-8072
Rebecca L StepienSchool of Veterinary Medicine, Medical Sciences, University of Wisconsin Madison, Madison, Wisconsin.
Mark A OyamaClinical Studies-Philadelphia, MJR-VHUP-Cardiology, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID https://orcid.org/0000-0002-5218-9226
Bruce W KeeneDepartment of Clinical Sciences, North Carolina State University, College of Veterinary Medicine, Raleigh, North Carolina.
John BonaguraDepartment of Veterinary Clinical Sciences, The Ohio State University, Columbus, Ohio.
Kristin A MacDonaldAnimal Care Center, Rohnert Park, California.
Mark PattesonHeartVets @ Vale Referrals, The Animal Hospital, Stinchcombe, Dursley Glos, UK.
Sarah SmithSarah Smith Cardiology, Derby, UK.
Philip R FoxDepartment of Cardiology and Caspary Research Institute, Animal Medical Center, New York, New York.ORCID https://orcid.org/0000-0003-4089-0573
Karen SandersonRocky Mountain Veterinary Cardiology, Boulder, Colorado.
Richard WoolleyCardio Respiratory Pet Referrals, Mordialloc, Melbourne, Victoria, Australia.
Viktor SzatmáriFaculty of Veterinary Medicine, Clinical Sciences of Companion Animals, Utrecht University, Utrecht, The Netherlands.ORCID https://orcid.org/0000-0002-0273-6586
Pierre MenautClinique Vétérinaire AQUIVET, Eysines, France.
Whitney M ChurchDesert Veterinary Medical Specialists, Phoenix, Arizona.
M Lynne O'SullivanDepartment of Companion Animals, Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, Prince Edward Island, Canada.
Jean-Philippe JaudonClinique Veterinaire Des Etangs, Villars Les Dombes, France.
Jan-Gerd KreskenClinic for Small Animals Kaiserberg, Duisburg, Germany.
John RushSchool of Veterinary Medicine, Clinical Sciences, Tufts University Cummings, North Grafton, Massachusetts.ORCID https://orcid.org/0000-0002-8277-8996
Kirstie A BarrettCardiology, VCA West Los Angeles, Los Angeles, California.
Steven L RosenthalCVCA Cardiac Care for Pets, Towson, Maryland.
Ashley B SaundersDepartment of Small Animal Clinical Sciences, Texas A&M University, College Station, Texas.ORCID https://orcid.org/0000-0001-9908-3894
Ingrid LjungvallDepartment of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden.
Michael DeinertFachtierarztpraxis Am Sandpfad, Wiesloch, Germany.
Eric BomassiCentre Hospitalier Vétérinaire des Cordeliers, Cardiology, Meaux, Paris, France.
Amara H EstradaUniversity of Florida College of Veterinary Medicine, Small Animal Clinical Sciences, Gainesville, Florida.
Maria J Fernandez Del PalacioMedicina y Cirugía Animal, Universidad de Murcia, Murcia, Spain.
N Sydney MoiseClinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York.
Jonathan A AbbottDepartment of Small Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, Virginia.ORCID https://orcid.org/0000-0001-6981-8968
Yoko FujiiAzabu University, Surgery 1, Kanagawa, Japan.
Alan SpierBlue Pearl Veterinary Partners, Tampa, Florida.
Michael W LuethyChicago Veterinary Emergency and Specialty Center, Chicago, Illinois.
Roberto A SantilliCardiology, Clinica Veterinaria Malpensa, Varese, Italy.
Masami UechiJapan Animal Specialty Medical Institute Inc., JASMINE Veterinary Cardiovascular Medical Center, Yokohama, Japan.
Anna TidholmDjursjukhuset Albano, Stockholm, Sweden.ORCID https://orcid.org/0000-0002-6277-3936
Christoph SchummerBoehringer Ingelheim, Animal Health, Ingelheim am Rhein, Germany.
Philip WatsonBoehringer Ingelheim, Animal Health, Ingelheim am Rhein, Germany.
Boehringer Ingelheim (Germany) · DESwedish University of Agricultural Sciences · SETexas College · USArizona Pain Specialists · USAzabu University · JPCentre de Recherche des Cordeliers · FRClinique de l'Yvette · FRCornell University · USDanderyds sjukhus · SEFondazione Audiologica Varese · ITInstitut für Medizinische Informatik, Biometrie und Epidemiologie · DEJapan Small Animal Medical Center · JPMarine Mammal Care Center · USNorth Carolina State University · USPartners In Care · USRocky Mountain Institute · USRoyal Veterinary College · GBSmith Family · AUThe Ohio State University · USThe Schwarzman Animal Medical Center · US

Funding

Boehringer Ingelheim Animal Health GmbH
6 · The paper itself

Abstract

backgroundThe Evaluation of pimobendan in dogs with cardiomegaly caused by preclinical myxomatous mitral valve disease (EPIC) study monitored dogs with myxomatous mitral valve disease (MMVD) as they developed congestive heart failure (CHF).

objectivesTo describe the changes in clinical and radiographic variables occurring as dogs with MMVD and cardiomegaly develop CHF, compared to similar dogs that do not develop CHF. ANIMALS: One hundred and thirty-five, and 73 dogs that did or did not develop CHF, respectively. MATERIALS AND

methodsThe following variables were evaluated in 2 groups of dogs (dogs that did or did not develop CHF): Heart rate (HR), clinic respiratory rate (RR), home-measured resting respiratory rate (RRR), rectal temperature (RT), body weight (BW), and vertebral heart sum (VHS). Absolute value and rate of change of each variable were calculated for each day a dog was in study. Daily means were calculated and plotted against time. The onset of CHF or last visit before leaving the study were set as reference time points.

resultsThe most extreme values and rate of change occurred in variables immediately before onset of CHF. Vertebral heart sum increased earliest. Heart rate, RR, and RRR also increased. Rectal temperature and BW decreased. Increases in RR and RRR were most extreme and occurred immediately before CHF. CONCLUSIONS AND CLINICAL IMPORTANCE: Dogs with MMVD and cardiomegaly experience increases in HR, RR, RRR, and VHS, and decreases in BW and RT as they develop CHF. The variables with highest absolute change and rate of change were RR and RRR. These findings reinforce the value of RR and RRR as indicators of impending or incipient CHF.

Indexed as

AnimalsCardiomegalyDog DiseasesDogsFemaleHeartHeart FailureHeart RateHeart Valve DiseasesMaleMitral ValveMitral Valve InsufficiencyRadiography, ThoracicRespiratory Ratecaninecardiovascularclinical epidemiologyclinical trialsheart failurephysical examinationradiology and diagnostic imaging

Identifiers

PMID32200574
PMCPMC7255670
OpenAlexW3012776431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.